William E. Rote

Chief Research Officer, Travere Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$16.4M

Companies

Latest trade

Sep 16, 2026

Companies

Travere Therapeutics, Inc.Chief Research Officer −$16.4M

Trades

TVTX Sold 112,850 shares at $63.33 · planned $7.1M Sep 16

TVTX Sold 96,198 shares at $62.25 · planned $6.0M Sep 15

TVTX Sold 2,763 shares at $43.95 · planned $0.1M May 6

TVTX Sold 9,100 shares at $39.09 · planned $0.4M Apr 22

TVTX Sold 12,446 shares at $32.87 · planned $0.4M Feb 3

TVTX Sold 60,000 shares at $40.10 · planned $2.4M Dec 24

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.